Recent Publications

ALLERGY & ASTHMA

Contribution of stress to asthma worsening through mast cell activation
Do Mast Cells Link Obesity and Asthma?
•  Mast Cells in Allergic and Inflammatory Diseases

A probable case report of stress-induced anaphylaxis

 

Arthritis

Mast cells and mast cell mediators as targets of dietary supplements
Chondroitin sulphate inhibits connective tissue mast cells
Mast Cell Deficient W/Wv Mice Lack Stress-Induced Increase In Serum Il-6 Levels, As Well As In Peripheral Crh And Vascular Permeability, A Model Of Rheumatoid Arthritis
Dietary Supplements For Arthritis And Other Inflammatory Conditions: Key Role Of Mast Cells And Benefit Of Combining Anti-Inflammatory And Proteoglycan Products


Autism

Algonot Autism 5.2.24

Theoharides drug interactions

Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

Autism drug interactions

Autism mast cells - BBA 2012

Autism serum IL-6, TNF, luteolin - Transl Psych 9-2015

Autism subtype brain allergy - Clin Therapeutics May 2013

Autism, brain inflammation - J Neuroinflammation 2012

Autism, high serum CRH, neurotensin, dog model - Transl Psych 2104

Autism, hippocampus, molecular profiling - medRxiv Oct 2022

Autism, mastocytosis - Intl J Immunopathol Pharmacol 2009

Autism, NeuroProtek - Clin Therapeutics May 2013

Autism, NeuroProtek - IJIP6 2012

Autism, Perinatal stress - BMC Peds 9-2012

Autism, serum NT

Mast cells, IL-37 - Intl J Mol Sci 2019

Molecular Profiling of the Hippocampus of Children with Autism Spectrum Disorder - Abstract - Europe PMC

Neuroinflammation, seizures, autism - J Neuroinflamm 2011

Neurotensin, autism - PNAS 2016

Perinatal mast cells, coronavirus, autism - J Pers Med 2021

Extracellular vesicles are increased in the serum of children with autism spectrum disorder

Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders

Extracellular Mitochondrial ATP, Suramin, and Autism?

Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6

Exosomes in Neurologic and Psychiatric Disorders

Potential Etiologic Factors of Microbiome Disruption in Autism

Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism

Mold andImmunity

Effects of Mycotoxinson Neuropsychiatric Symptoms andImmuneProcesses

Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders

Autism Drugs in Wealthy Nations

Elevated serum neurotensin and CRH levels in children with
autistic spectrum disorders...

Extracellular Mitochondrial ATP, Suramin ,and Autism?
Extracellular Mitochondrial Components Secreted from Activated Live Mast Cells Act as “Innate Pathogens” and Contribute to Autism Pathogenesis
The “missing link” in autoimmunity and autism: Extracellular mitochondrial components secreted from activated live mast cells
Focal Brain Inflammation and Autism
NeuroProtek - 2012
Autism, Seizures, JNI 2012
Autism, Allergies JADD
Inflammatory Conditions (Quicktime video)
The Immune System & Autism (Quicktime/Flash Video)
Novel therapeutic targets for autism
Mast cells as targets of corticotropin releasing factor and related peptides
Critical role of mast cells in inflammatory diseases and
the effect of acute stress

Autism: an emerging ‘neuroimmune disorder’ in search of therapy
Autism Spectrum Disorders and Mastocytosis
Mercury induces inflammatory mediator release from human mast cells
Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children
Neurotensin is increased in serum of young children with autistic disorder

 

AUTISM DIAGNOSIS & TREATMENT

Children with Autism Spectrum Disorders

 

BLADDER HEALTH

CystoProtek clinical Can J Urol

Cystoprotek IJIP

Genitourinary mast cells 2015

Interstitial cystitis-bladder pain syndrome - J Family Practice 6-2011

Intimate contact - Clin Ther 2019

 

BRAIN ALLERGY

Atopic conditions, Clin Therapeutics May 2013

Autism subtype brain allergy Clin Therapeutics May 2013

Autism, allergies, JADD 2011

 

BRAIN FOG

Brain Fog - Frontiers Neuroscience - July 2015

Brain inflammation, Long-COVID - Cells 2023

Luteolin, Long-COVID brain fog - Biofactors 2021

 

BRAIN HEALTH

Stress Blood Brain Barrier

Brain Inflammation

Non-steroidal Drugs Inhibit SSRI Antidepressant Action

Mast Cells - The Immune Gate to the Brain

 

Brain Inflammation

Atopic Diseases and Inflammation of the brain in the pathogenesis of autism spectrum disorders

Autism, brain inflammation, J Neuroinflammation 2012

Brain inflammation, Long-COVID, Cells 2023

Brain mast cells chapter, Theoharides 2022

Brain mast cells, Eur J Pharmacol July 2015

Exosomes, brain, Clin Therap 2014

Factors affecting neurodevelopment, J Reg Homeost Agents 2019

FMS biomarkers, JPET 2016

FMS, JPET 2015

Gut Brain Axis and Neuroimmune disorder, Clin Therap May 2015

Mast cells in meningiomas and brain inflammation 2016

Mast cells, brain inflammation and autism, Eur J Pharmacol 2016

Stress, inflammation, Clin Ther 2020

Stress, inflammation, autoimmunity, Clin Ther May 2020

Stress, mast cells, Annals Allergy, Asthma Immunol 2020

Stress, MS Autoimmuni Rev 2013

Stress, natural treatments, J Reg Hoemost Agents 2019

The “missing link” in autoimmunity and autism, Autoimm Rev 2013

Brain Inflammation, Neuropsychiatric Disorders, and Immunoendocrine Effects of Luteolin
Histochemical and Ultrastructural Characteristics of Rat Barin Perivascular Mast Cell Stimulated With Compound 48/80 and Carabachol
Definitive Characterization of Rat Hypothalamic Mast Cells
The role of mast cells in migraine pathophysiology
Corticotropin-releasing hormone and the blood-brain-barrier
Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress
Definitive Characterization of Rat Hypothalamic Mast Cells
Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis
Critical role of mast cells in inflammatory diseases and the effect of acute stress
Acute stress increases permeability of the blood–brain-barrier through activation of brain mast cells
Non-invasive assessment of blood–brain barrier (BBB) permeability using a gamma camera to detect 99technetium-gluceptate extravasation in rat brain
Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice

 

Cancer

Mast cells and pancreatic cancer
Mast cells: the JEKYLL and HYDE of tumor growth
Brain metastases of mouse mammary adenocarcinoma is increased by acute stress
Impact of stress and mast cells on brain metastases
Mast Cells and Tumor Microenvironment


Cardiovascular Diseases

Mast cells squeeze the heart and stretch the gird
Stress triggers coronary mast cells leading to cardiac events

The Role of Mast Cells in Acute Coronary Syndromes
Sites of Interleukin-6 Release in Patients With Acute Coronary Syndromes and in Patients With Congestive Heart Failure
Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice
IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells
Kounis Syndrome (Allergic Angina and Allergic Myocardial Infarction)
Coronary Stents, Hypersensitivity Reactions, and the Kounis Syndrome
The flavonoid luteolin inhibits niacin-induced flush
Allergic Inflammation and Adipocytokines
The flavonoid luteolin inhibits niacin-induced flush
Niacin-induced "Flush" Involves Release of Prostaglandin D2 from Mast Cells and Serotonin from Platelets: Evidence from Human Cells in Vitro and an Animal Model
Mast Cell Deficient W/W Mice Have Lower Serum IL-6 and Less Cardiac Tissue Necrosis Than Their Normal Littermates Following Myocardial Ischemia-Reperfusion
Mast cell tryptase: a new biomarker in patients with stable coronary artery disease
Mast cell tryptase: a new biomarker in patients with stable coronary artery disease
Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kB activation


COVID-19

Calprotectin, inflammation, COVID-19 - 2022

COVID-19, mast cells, luteolin highlights

COVID-19, PAF, microthromboses - 2020

COVID, mast cells, treatment - 2022

Spike protein, mast cell, microgia, neuro-COVID Cells - 2023

Spike proten stimulates mast cells via TLR4

Spike, coronavirus, long-COVID - 2022

Brain inflammation, Long-COVID - Cells 2023

Luteolin, Long-COVID brain fog - Biofactors 2021

SARS-CoV-2 Spike, Microglia, Neuroinflammation, Receptors - Molecular Neurobiology

•  Spike Protein, Mast Cell, Microgia, Neuro-COVID - Cells, 2023

Spike Proten Stimulates Mast Cells via TLR4 - IJMS

Spike-proten-stimulates-mast-cells-via-TLR4_IJMS

Mast cells and SARS-CoV-2

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID

COVID-19 and multisystem inflammatory syndrome

• COVID-19 brain inflammation and autism spectrum disorder

• COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin

• COVID-19, microthromboses, inflammation, and platelet activating factor

Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue

Luteolin supplements: All that glitters is not gold

Potential association of mast cells with coronavirus disease 2019

•  Be aware of SARS-CoV-2 spike protein: There is more than meets the eye

 


Fibromyalgia / Chronic Fatigue ►

Click the link above to learn more.

 

 

Flavonoids ►

Click the link above to learn more.

New Evidence indicates that the flavonoid luteolin is a better inhibitor of mast cells than the drug cromolyn

Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus

Luteolin Isolated from Juncus acutus L., a Potential Remedy for Human Coronavirus 229E

Luteolin is a potential inhibitor of COVID-19: An in silico analysis

Covid-19, Mast Cells, Lueolin Highlights

Luteolin - Neurotrauma 2020

Mast Cell Activation Beyond Histamine And Tryptase - exp Rev Clin Immunol 2023

Mast Cells, Microglia - neuro-covid cells 2023

Sars-CoC-2 Spike Protein Mast Cells - ijms, 2023

Sars-CoV-2 Spike Protein, Microglia - mol Neurobiol 2023

Sars‐CoV‐2 Spike Protein And Paf - biofactors 2022

Spike Protein, Mast Cell, Microgia, Neuro-covid cells 2023

Spike, Coronavirus, Long-covid - mol Neurobiol-nature 2002

Covid Treatment, Mast Cells - intl J Inf Dis 2022

Kempuraj - luteolin 2020

Luteolin supplements- All that glitters is not gold - Biofactors 2020

Luteolin - Neuropsychiatric Disorders

Luteolin, COVID-19, mast cells, cytokines - BioFactors 2020

Luteolin, Long-COVID brain fog - Biofactors 2021

Luteolin, MS - J Neuroinflamm 2009

Luteolin, Post-Lyme - 2016

Methlut lotion - Intl J Immunpath Pharm 2017

Methoxyluteolin, mast cells - JACI 2015

Methoxyluteolin, mast cells - mTOR, JPET 2017

Autism, elevated serum CRH, NT-Transl Psych 2014

Autism, NeuroProtek Clin Therapeutics May 2013

Autism, NeuroProtek, IJIP6-2012

Mast cells, stress, fear, autism, Intl J Mol Sci 2019

Theoharides Autism, basis NeuroProtek in Autism Science Digest 2010

CFS , flavones J Neuroinflamm 2014

Mast cells, COVID-19_Annals Allergy Asthma 2021

 


Interstitial Cystitis

 

 

 

 

 

 

Interstitial Cystitis Bladder Pain Syndrome
When to Suspect Interstitial Cystitis
Inflammatory Conditions (Quicktime video)
CystoProtek® (video)
Increased Numbers of Activated Mast Cells in Endometriosis Lesions Positive for Corticotropin-Releasing Hormone and Urocortin
Treatment of refractory interstitial cystitis/
painful bladder syndrome with CystoProtek
– an oral multi-agent natural supplement

A Pilot Open Label Study Of Cystoprotek In Interstitial Cystitis
New agents for the medical treatment of interstitial cystitis
Interstitial cystitis: bladder pain and beyond
Acute Stress and Intravesical Corticotropin-Releasing Hormone Induces Mast Cell Dependent Vascular Endothelial Growth Factor Release From Mouse Bladder Explants
Intravesical Nanocrystalline Silver Decreases Experimental Bladder Inflammation
Intravesical Suplatast Tosilate (IPD-1151T) Inhibits Experimental Bladder Inflammation
The Mast Cell in Interstitial Cystitis: Role in
Pathophysiology and Pathogenesis

Immunomodulators For Treatment Of Interstitial Cystitis

 

IRRITABLE BOWEL SYNDROME

Mast Cells in Irritable Bowel Syndrome and Ulcerative Colitis

 

Mast Cells

• Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via regulation of JAK1/STAT3 pathway

• Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells

• Luteolin is a potential inhibitor of COVID-19

Mast Cell Over-Activation, and How it Affects our Mind and Body Well-Being. (Passcode: q*bwPX3M)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

• What do mast cells "Mast Cell Activation Disorder" have to do with pain, fatigue, allergies and even autism?  Click the blogtalkradio logo button below to listen to the answer.
blogtalkwhite

Mast cells and pain, International Association for the Study of Pain

 

 

Mast Cells and Inflammation

• Podcast: Mast Cell Matters: Deep dives on MCAS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Mast cells, Pancreatitis_2014

Mast cell activation and microbiome

Mast cell activation beyond histamine and tryptase Exp-Rev-Clin-Immunol_2023

Mast cell activation disorders, Exp Rev Clin Immunol 2014

Mast cell mediator disorder, Exp Rev Clin Imminol 2019

Mast cell, obesity asthma, Allergy 2014

Mast cells and COVID-19_medRxiv_2022

Mast cells and SARS-CoV-2_NEJM, 2023

• Mast cells in allergy inflamm Curr Pharm Des 2012

Mast cells brain inflammation and autism Eur J Pharmacol 2016

Mast cells, COVID-19_Annals Allergy Asthma 2021

Mast cells, dendritic cells_JACI 2021

Mast cells, fear, autism, Intl J Mol Sci 2019

Mast cells, FMS, pain, Front Cell Neurosci 2019

Mast cells, IBS, Dig Dis Sc 2014

Mast cells, IL-1 beta, PNAS 9-2018

• Mast cells, IL-37, Intl J Mol Sci, 2019

Mast cells, Immunity_IJMS 2023

Mast cells, inflammation, BBA 2012

Mast cells, mastocytosis and supplemental, NEJM July 9, 2015

Mast cells, meningiomas_J Neuroinflam, 2015

Mast cells, migraines_Brain Res Rev, 2005

Mast cells, MS, strress, Autoimm Rev, 2013

Mast cells, neuroinflammation_Front Cell Neurosc, 2019

Mast cells, neuron contacts, Clin Ther 2016 main

Mast cells, obesity, MI, Trends Pharm Sc 2011

Mast cells, pancreatic cancer_NEJM, 2008

Mast cells, stress, asthma Ann Allergy Asthma Immunol 2012

Mast cells, stress, fear, autism, Intl J Mol Sci 2019

Mast cells, stress, heart, Ann Allergy Asthma Immunol 2014

Mastocytose - fatigue

Mastocytosis, cognitive impairment 2012

Mast cell activation: beyond histamine and tryptase

Substance P and IL-33 administered together stimulate a marked secretion...

Danger Signals and Inflammation

Neuropeptides and Inflammatory Cytokines Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Fybromyalgia Syndrome in Need of Effective Treatments

• SP and IL-33 together markedly enhance TNF synthesis
and secretion from human mast cells mediated by the
interaction of their receptors

Targeting IL-33 in Autoimmunity and Inflammation

Mast Cells in Meningiomas and Brain Inflammation

Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cellss

Neuroendocrinology of Mast Cells

Vitamin D and Atopy

Antihistamines and Mental Status

Mast cells and inflammation
Use of Polyphenols in Periodontal Inflammation

Differential release of mast cell mediators and the pathogenesis of inflammation
Critical role of mast cells in inflammatory diseases and the effect of acute stress
The Critical Role of Mast Cells in Allergy and Inflammation

 

Mastocytosis

Spectrum of Mast Cell Activation Disorders

Mast Cells, Mastocytosis and Related Disorders

• Neuroendocrinology of Mast Cells: Challenges and
Controversies

The Mast Cell: A Cell for All Seasons
Quercetin Better Than Cromolyn
CRH, BBB-Bioscience Differential release of mast cell mediators and the pathogenesis of inflammation
Neuroimmunoendocrine circuitry of the ‘brain-skin connection’
Secondary Anetoderma Associated with Mastocytosis
Acute Stress-Induced Seizures and Loss of Consciousnenn in a Ten-Year-Old Boy With Cutaneous Mastocytosis
Urticaria pigmentosa associated with acute stress and lesional skin mast-cell expression of CRF-R1


Migraines

The role of mast cells in migraine pathophysiology
Corticotropin-releasing hormone and the blood-brain-barrier
Morphological and functional demonstration of rat dura mater mast cell–neuron interactions in vitro and in vivo
Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis
Corticotropin-Releasing Hormone and Its Structurally Related Urocortin Are Synthesized and Secreted by Human Mast Cells
Mast Cells: The Immune Gate To The Brain
Migraine Headaches: The Immunologist's View
Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice
Stress-Induced Intracranial Mast Cell Degranulation: A Corticotropin-Releasing Hormone-Mediated Effect
Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice
Mast cells as targets of corticotropin- releasing factor and related peptides

 

Multiple Sclerosis

IJIP MS Hydroxyzine
Luteolin, MS, TCT, J Neuroinflam 11-09
Luteolin, T cells, mast cells BJP 2008
Monkey EAE
Mast Cells The Immune Gate to the Brain LIfe Sciences 1990
MBB, estradiol activate brain mast cells, demyelination, Neuroscience

 

Pathogenesis

Neuroinflammation and Autism

 

 

Skin Diseases

Natural remedy may stop psoriasis flares before they start

Impact of Mast Cells on the Skin

Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process
Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor
Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway
Acute Stress Results in Skin Corticotropin- Releasing Hormone Secretion, Mast Cell Activation and Vascular Permeability, an Effect Mimicked by Intradermal Corticotropin- Releasing Hormone and Inhibited
by Histamine-1 Receptor Antagonists

Skin Corticotropin-Releasing Hormone Receptor Expression in Psoriasis
IL-33 augments substance P–induced VEGF secretion
from human mast cells and is increased in psoriatic skin

Corticotropin-Releasing Hormone Receptor-1 and Histidine Decarboxylase Expression in Chronic Urticaria
A Quercetin Containing Supplement Reduces Niacin-Induced Flush In Humans
Rupatadine Inhibits Proinflammatory Mediator Secretion from Human Mast Cells Triggered by Different Stimuli
Neuroimmunoendocrine circuitry of the 'brain-skin connection'
Potent Mast Cell Degranulation and Vascular Permeability Triggered by Urocortin Through Activation of Corticotropin- Releasing Hormone Receptors
Urticaria pigmentosa associated with acute stress and lesional skin mast-cell expression of CRF-R1

 

 

SUPPLIMENTS

• Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via regulation of JAK1/STAT3 pathway

• Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells

• Luteolin is a potential inhibitor of COVID-19

Luteolin Hormonal Effects
Luteolin, Post-Lyme s., 2016
Luteolin, Long-COVID brain fog_Biofactors 2021
Luteolin, MS_J Neuroinflamm 2009
Luteolin, COVID-19, mast cells, cytokines_BioFactors 2020
Luteolin- Neuropsychiatric Disorders
Luteolin supplements- All that glitters is not gold_Biofactors 2020
Methoxyluteolin, mast cells, JACI 2015
Methoxyluteolin, mast cells, mTOR, JPET 2017
Methlut lotion, Intl J Immunpath Pharm 2017 

 

 

TRIGEMINAL

Trigeminal nerve stimulation triggers oral mast cell activation and vascular permeability

 

 

Relevant recent reviews (2010 - 2011) include:

 

Pandolfi F, Cianci R, Cammarota G, Pagliari D, Landolfi R, Conti P, Theoharides TC. Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. Ann Clin Lab Sci 40(1):3-9, 2010.

 

Manola, A., Kourelis, T., Angelidou A, Theoharides, TC. Mast cell mediators and inflammatory diseases. In Kounis Syndrome: The Coronary Hypersensitivity Syndrome (Nicholas G. Kounis, ed.). Nova Science Publishers: Hauppauge, N.Y, 2010.

 

Kourelis, T., Manola, A., Alysandratos K-D, Theoharides, TC. Mast cell activation. In Kounis Syndrome: The Coronary Hypersensitivity Syndrome (Nicholas G. Kounis, ed.). Nova Science Publishers: Hauppauge, N.Y, 2010.

 

Castellani ML, Anogeianaki A, Felaco P, Toniato E, De Lutiis MA, Shaik B, Fulcheri M, Vecchiet J, Tetè S, Salini V, Theoharides TC, Caraffa A, Antinolfi P, Frydas I, Conti P, Cuccurullo C, Ciampoli C, Cerulli G, Kempuraj D. IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. J Biol Regul Homeost Agents 24(2):131-5, 2010.

 

Castellani ML, De Lutiis MA, Toniato E, Conti F, Felaco P, Fulcheri M, Theoharides TC, Caraffa A, Antinolfi P, Conti P, Cuccurullo C, Ciampoli C, Felaco M, Orso C, Salini V, Cerulli G, Kempuraj D, Tetè S, Shaik B. Impact of RANTES, MCP-1 and IL-8 in mast cells. J Biol Regul Homeost Agent 24(1):1-6, 2010.

 

Castellani ML, Felaco P, Galzio RJ, Tripodi D, Toniato E, De Lutiis MA, Fulcheri M, Caraffa A, Antinolfi P, Tete S, Felaco M, Conti F, Pandolfi F, Theoharides TC, Shaik-Dasthagirisaheb YB. IL-31 a Th2 cytokine involved in immunity and inflammation. Int J Immunopathol Pharmacol 23(3):709-13, 2010.

 

Castellani ML, Galzio RJ, Felaco P, Tripodi D, Toniato E, De Lutiis MA, Conti F, Fulcheri M, Conti C, Theoharides TC, Caraffa A, Antinolfi P, Felaco M, Tete S, Pandolfi F, Shaik-Dasthagirisaheb YB. VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents 24(3):229-37, 2010.

 

Castellani ML, Anogeianaki A, Felaco P, Toniato E, De Lutiis MA, Shaik B, Fulcheri M, Vecchiet J, Tetè S, Salini V, Theoharides TC, Caraffa A, Antinolfi P, Frydas I, Conti P, Cuccurullo C, Ciampoli C, Cerulli G, Kempuraj D. IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. J Biol Regul Homeost Agents 24(2):131-5, 2010. 52

 

Castellani ML, De Lutiis MA, Toniato E, Conti F, Felaco P, Fulcheri M, Theoharides TC, Caraffa A, Antinolfi P, Conti P, Cuccurullo C, Ciampoli C, Felaco M, Orso C, Salini V, Cerulli G, Kempuraj D, Tetè S, Shaik B. Impact of RANTES, MCP-1 and IL-8 in mast cells. J Biol Regul Homeost Agents 24(1):1-6, 2010.

 

Castellani ML, Galzio RJ, Felaco P, Tripodi D, Toniato E, De Lutiis MA, Conti F, Fulcheri M, Conti C, Theoharides TC, Caraffa A, Antinolfi P, Felaco M, Tete S, Pandolfi F, Shaik-Dasthagirisaheb YB. VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents 24(3):229-37, 2010.

 

Castellani ML, Felaco P, Galzio RJ, Tripodi D, Toniato E, De Lutiis MA, Fulcheri M, Caraffa A, Antinolfi P, Tetè S, Felaco M, Conti F, Pandolfi F, Theoharides TC, Shaik-Dasthagirisaheb YB. IL-31 a Th2 cytokine involved in immunity and inflammation. Int J Immunopathol Pharmacol 23(3):709-13, 2010.

 

Anogeianaki A, Castellani ML, Tripodi D, Toniato E, DeLutiis MA, Conti F, Felaco P, Fulcheri M, Theoharides TC, Galzio R, Caraffa A, Antinolfi P, Cuccurullo C, Ciampoli C, Felaco M, Cerulli G, Pandolfi F, Sabatino G, Neri G, Shaik-Dasthagirisaheb YB. Vitmains and mast cells. Int J Immunopathol Pharmacol, in press, 2010.

 

Angelidou A, Alysandratos K-D, Asadi S, Zhang B, Francis K, Vasiadi M, Kalogeromitros D, Theoharides TC. Neonatal mast cell activation and autism. More than meets the eye? J Autism Dev Disorders, in press, 2011.

 

Whitmore, K.., Theoharides, T.C., Interstitial cystitis/bladder pain syndrome. J Family Practice, in press, 2011.

 

Theoharides TC, Angelidou A, Alysandratos K-D, Zhang BD, Asadi S, Francis K, Toniato E, Kalogeromitros D. Mast cell activation and autism. Biochim Biophys Acta. 2011, in press.

 

Theoharides TC, Angelidou A, Alysandratos K-D, Zhang BD, Sismanopoulos N, Delivane D, Vasiadi M, Asadi S, Miniati A, Kalogeromitros D. Mast cells and inflammation. Biochim Biophys Acta. 2011, in press.

 

Theoharides, T.C. Kourembanas, S. Perinatal stress and risk for autism. In preparation.

 

Alysandratos K-D, Angelidou A, Papadimas E, Dizon P, Theoharides TC. Stress gets the lungs sqeezing and wheezing. In preparation.

 

 

 

 

upcoming events
16-18 Mar

MAPS SPRING 2023
Functional & Translational Medicine Conferance MARCH 16-18, 2023 at Charlotte, NC
Event Website

 

4 Apr

FREE WEBINAR
Mast Cell Over-Activation, and How it Affects our Mind and Body Wellbeing
Thursday, April 4th 1:00 PM EDT | 19:00 (Copenhagen)
Location: Zoon
Send an email to mastcell@neurodiversitet.net about your participation. A Zoom link will be shared in response.

 

Greek Presentations

Το σύνδρομο του Long Covid και η εξατομικευμένη προστασία από τον κορονοϊό

Long Covid Syndrome και εξατομικευμένη προστασία από τον κορονοϊό

Presentation 01 / PDF Details

 

Prof. Theoharides' Invited Lectures (2015-17)

  • • Australia Autism Lecture (April 24, 2015; Melbourne, Australia)
  • • Boston Conservatory of Music (May 5, 2015; Boston, MA)
  • • Autism Education Summit (September 26, 2015; Dallas, TX)
  • • National Autism Association (October 15, 2015; St. Pete, FL)
  • • Autism Research Institute (December 5, 2015; Boston, MA, 2015)
  • • Cyprus Pediatric Association (February 14, 2016; Nicosia, CY)
  • • TARF Think Tank (February 19, 2016; Boston, MA)
  • • NCIMS (February 27, 2016;Greenboro, NC)
  • • TACA Massachusetts (March 12, 2016; Watertown MA)
  • • 11th PanHellenic Conference on Allergy & Clinical Immunology (April 16, 2016; Athens, Greece)
  • • TACA Webinar (April 25, 2016; 1 pm)
  • • All Childrens Hospital (April 1, 2016; St. Pete, FL)
  • • TACA Philadelphia (May 7, 2016; Philadelphia, PA)
  • • Autism One (May 27, 2016; Chicago, IL)
  • • Autism One Think Tank (May 28, 2016; Chicago, IL)
  • • EAAACI (June 7-11, 2017; Vienna, Austria)
  • • Old North State Medical Society (June 23-25, 2016; Raleigh, NC)
  • • FASEB Summer Research Conference in the long-running Neuroimmunology series entitled "Translational Neuroimmunology: From Mechanisms to Therapeutics" (July 24-29, 2016; Big Sky, MT)
  • • 11th Annual USAAA World Autism and Asperger Conference (August 29, 2016; Louisville, KY)
  • • MAPS Conference (September 9, 2016; Atlanta, GA)
  • • The Mastocytosis Society (September 15-17, 2016; Orlando, FL)
  • • International College of Geriatric Psychoneuropharmacology (ICGP) (October 7, 2016; Athens, Greece)
  • • TACA National Conference (October 22, 2016; Costa Mesa, CA)
  • • ILADS Annual meeting (November 4, 2016; Philadelphia, PA)
  • • 37th UMEMPS (Union of Middle-Eastern and Mediterranean Pediatric Societies-Cyprus Pediatric Society (November 6, 2016; Limassol, Cyprus)
  • • 1st International Conference on Autism (November 22, 2016; Paphos, Cyprus)
  • • Nashville Support Group Meeting - Saturday, September 16, 2017 10a-4p Hermitage Library, 3700 James Kay Lane, Hermitage, TN 37076 Speaker: Dr. Theoharides, MD

  • • Brain Fires in Autism: Mast Cells, Microglia and Brain Inflammation - Hilton Orange County Hotel in Costa Mesa, BELIEVE room 2 – 8:00AM October 2017.
  • • Stress, Brain Inflammation and Brain Fog in Autism - Hilton Orange County Hotel in Costa Mesa, BELIEVE room 2 – 8:00AM October 2017
  • • Bari (Italy), 2nd European Conference of Biomedical Research and Treatments of Autism - Mast cell-microglia connection leading to focal inflammation of the brain in autism Saturday @ 15.40 - Brochure (PDF) November 2017
  • • Queen Mary University of London, 15:30-15:30-Regulatory systems pathway from stress to disease and possible parallels to periodontal disease Email: a.b.o.gamboa@qmul.ac.uk November 2017
  • • Queen Mary University of London, 15:30-16:00-Interventions on the immune regulatory systems Email: a.b.o.gamboa@qmul.ac.uk November 2017
  • • Conway Hall, London, 10:00 am, Brain Fires in Autism: Mast Cells, Microglia and Inflammation of the Brain December 2017
  • • Conway Hall, London, 10:00 am, Role of Mast Cells in Inflammatory Diseases December 2017

EAAACI=European Academy of Allergy and Clinical Immunology
ILADS=International Lyme and Associated Diseases Society
MAPS=Medical Academy of Pediatrics  Se-0pcial Needs
NCIMS=North Carolina Integrative Medical Society
TARF=The Autism Research Foundation
TACA=Think About Curing Autism
ILADS=International Lyme and Associated Diseases Society


Websites

www.gentlederm.com
www.brain-gate.org

How to Explain Autism to Children
https://indyschild.com/how-to-explain-autism-to-children/

Creating the Ultimate Sensory Room for Your Toddler
https://localbabysitter.com/creating-the-ultimate-sensory-room-for-your-toddler/

Top Safety Tips and Products for Kids With Autism
https://www.verywellhealth.com/top-autism-safety-tips-and-products-4143117

How Nutrition Impacts Children With Autism
https://thefoodoasis.com/how-nutrition-impacts-children-with-autism/

12 Popular Games Adapted for Children with Autism
http://blog.stageslearning.com/blog/12-popular-games-adapted-for-children-with-autism

18 Social Skills Activities for Kids with Autism and Sensory Issues
https://www.merakilane.com/18-social-skills-activities-for-kids-with-autism-and-sensory-issues/

Home of the Low Histamine Chef - Jasmina Ykelenstam
healinghistamine.com


 

 

 

Quick contact